Skip to content

A study of aasyasukham swapnasukham as behavioral risk factor in madhumeha (type 2 dm) and randomised comparative trial of intervention shilajatu vati with and wuthout satvavajay chikitsa

A CASE CONTROL STUDY OF AASYASUKHAM SWAPNASUKHAM AS BEHAVIORAL RISK FACTOR IN MADHUMEHA (TYPE 2 DM) AND RANDOMIZED COMPARATIVE TRIAL OF SHILAJATU VATI WITH AND WITHOUT SATVAVAJAYA CHIKITSA Xx - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070891
Enrollment
30
Registered
2024-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex in the age group of 18-70 years. Diagnosed cases of Type 2 DM. Matched control group of participants without type 2 DM.

Exclusion criteria

Exclusion criteria: Patients of Type 1 DM/IDDM taking insulin therapy. ? Patients having chronic complications of Diabetes mellitus. Microvascular: Retinopathy, Neuropathy and Nephropathy. Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro vascular diseas Patients suffering from major systemic disorders like renal disease, cardiac disease, thyroid disease, any malignancy, contagious disease.

Design outcomes

Primary

MeasureTime frame
Change in FBS, PPBS, HbA1c after intervention of Shilajatu vati with and without Satvavjaya chikitsa at the end of day 90Timepoint: Change in FBS, PPBS, HbA1c after intervention of Shilajatu vati with and without Satvavjaya chikitsa at the end of day 90

Secondary

MeasureTime frame
Change in Ayurvedic Symptoms Score after intervention of Satvavjaya Chikitsa and Shilajatu Vati at the end of day 90Timepoint: At the end of 90 days

Countries

India

Contacts

Public ContactProf Surendra Kumar Sharma

National Institute of Ayurveda

drsksm31@rediffmail.com919414361874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026